Dual Mobility Implant
DevicePatients in this intervention will receive a dual mobility implant
NCT Number: NCT04090359
The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 4
New York University Medical Center, New York, United States
The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in this intervention will receive a dual mobility implant
Patients in this intervention will receive a conventional, single-bearing implant
Time frame: 6 weeks
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Time frame: 3 months
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Time frame: 2 years
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Time frame: 5 years
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Time frame: 10 years
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Time frame: 15 years
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Time frame: 20 years
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Time frame: up to 20 years after the patient is discharged from the hospital
Any peri- or postoperative complications will be recorded, including component loosening, occurrence of intraprosthetic dislocation, infection, periprosthetic fractures, revision rates
Time frame: 6 weeks
Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.
Time frame: 3 months
Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.
Time frame: 2 years
Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.
Time frame: 5 years
Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.
Time frame: 10 years
Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.
Time frame: 15 years
Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.
Time frame: 20 years.
Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.
Contact information is provided by the study sponsor or research team.
Anne DeBenedetti, BA
CONTACT
Craig Della Valle, MD
CONTACT
Rush University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05587244
Arthritis, Arthritis, Rheumatoid
Birmingham, Alabama, United States
View Trial DetailsNCT04092634
Dislocation, Hip, Hip Dislocation
Los Angeles, California, United States
View Trial DetailsNCT05548972
Arthritis, Arthritis, Rheumatoid
Little Rock, Arkansas, United States
View Trial DetailsNCT06639334
Dislocation, Hip, Hip Dislocation
View Trial Details